Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Colorectal Neoplasms 14Lung Neoplasms 9Stomach Neoplasms 5Neoplasms 5Neoplasm Metastasis 5Colonic Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Small Cell Lung Carcinoma 4Rectal Neoplasms 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Esophageal Neoplasms 4Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Pancreatic Ductal 3Peritoneal Neoplasms 2Mesothelioma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Vipoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thymoma 1Spinocerebellar Degenerations 1Somatostatinoma 1Sezary Syndrome 1Pseudomyxoma Peritonei 1

Interventions

trametinib 3dabrafenib 3binimetinib 2Trastuzumab 2Paclitaxel 2Nivolumab 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Docetaxel 2ulixertinib 1trastuzumab biosimilar HLX02 1sapanisertib 1romidepsin 1ripretinib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1liposomal doxorubicin 1larotrectinib 1ipatasertib 1glutathione pegylated liposomal doxorubicin 1erdafitinib 1entinostat 1diazepinomicin 1defactinib 1copanlisib 1cobimetinib 1clevudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Leucovorin × Thoracic × Clear all
NCT05355701 2026-06-05

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡